| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Interest Income | 0 | -100.000% | 31,793 | 52,218 | 51,909 | 60,546 |
| Interest Expense | (209) | -- | 0 | (20) | (108) | (200) |
| Net Interest Income | (209) | -- | 31,793 | 52,197 | 51,801 | 60,346 |
| Other Operating Income | 734 | -48.058% | 1,412 | 1,786 | 3,342 | 4,127 |
| Total Operating Income | 525 | -98.420% | 33,205 | 53,983 | 55,143 | 64,473 |
| Net Insurance Claims Incurred & Movement in Policyholders' Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Net Operating Income | 525 | -98.420% | 33,205 | 53,983 | 55,143 | 64,473 |
| Operating Expenses | (5,646) | -26.402% | (7,671) | (10,607) | (15,757) | (11,488) |
| Impairment Losses on Loans & Advances | (120) | -99.987% | (900,963) | (51,612) | (51,565) | (46,944) |
| Other Impairment Losses | (11,431) | -93.507% | (176,046) | (2,157) | 898 | 452 |
| Operating Profit / (Loss) | (16,671) | -98.414% | (1,051,475) | (10,392) | (11,282) | 6,492 |
| Change in FV & Impairment on Inv. Prop. | 0 | -- | 0 | 0 | 0 | 0 |
| Change in FV & Impairment on Others | 0 | -- | 0 | 0 | 0 | 0 |
| Profit / (Loss) on Disposal | 0 | -- | 0 | 0 | 0 | 0 |
| Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | (83) |
| Profit / (Loss) before Taxation | (16,671) | -98.414% | (1,051,475) | (10,392) | (11,282) | 6,409 |
| Taxation | 0 | -- | (19,016) | 2,032 | 1,497 | (1,848) |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- |
| Non-controlling Interests | (112) | -- | 294 | 128 | 163 | 0 |
| Others | -- | -- | -- | -- | -- | -- |
| Profit / (Loss) Attributable to Shareholders | (16,784) | -98.432% | (1,070,197) | (8,233) | (9,622) | 4,561 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Depreciation & Amortisation | -- | -- | -- | 1,528 | 1,831 | 1,999 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Qualified | -- | Disclaimer | Unqualified | Unqualified | Unqualified |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -3.000 | -98.315% | -178.000 | -1.000 | -2.000 | 1.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | (0.004) | (0.141) | 0.143 |
| NBV per share ($) | (0.363) | -- | (0.335) | 1.450 | 1.464 | 1.480 |
| Remarks: | Real time quote last updated: 07/10/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -7,051 |
| %Change | 5.323% |
| EPS / (LPS) | RMB -0.010 |
| NBV Per Share (¥) | RMB -0.374 |